Andrew Dillin investigates the molecular pathways of aging, focusing on how protein folding and conformations play a role in the aging process of cells and organisms and how diet can affect that link. He earned his B.S. in biochemistry from the University of Nevada, obtained his Ph.D. in genetics from UC Berkeley and did his postdoctoral training with Cynthia Kenyon at UCSF, studying the genetics of aging in nematodes. He is currently a Howard Hughes Medical Investigator, a professor of molecular and cell biology and co-director of the Paul F. Glenn Center for Aging Research, a collaboration between UC Berkeley and UC San Francisco. In 2008, he co-founded Proteostasis Therapeutics and remains an active member of its scientific advisory board.